Metraipolis › archive › dc_4e8d322d8d8e

Neoadjuvant chemotherapy-induced immune remodeling in ovarian cancer: implications for TIL dynamics and combination immunotherapy — Europe PMC PMID:41798957

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41798957
DOI
10.3389/fimmu.2026.1757366
License (as archived)
solo-consultazione
Archived
2026-11-05T15:07:55.825Z
SHA-256 of the archived text
654be182cf8f80e8c8bb8a0905dd271241e56550efdc24f2d106da02b4fdb27a
Stable URL of this page
https://metraipolis.com/documento/dc_4e8d322d8d8e

How to cite

Neoadjuvant chemotherapy-induced immune remodeling in ovarian cancer: implications for TIL dynamics and combination immunotherapy — Europe PMC PMID:41798957 — Europe PMC (en), https://europepmc.org/article/MED/41798957 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e8d322d8d8e (Metraipolis archive dc_4e8d322d8d8e, sha256 654be182cf8f80e8c8bb8a0905dd271241e56550efdc24f2d106da02b4fdb27a)
BibTeX
@misc{dc4e8d322d8d8e,
  title = {Neoadjuvant chemotherapy-induced immune remodeling in ovarian cancer: implications for TIL dynamics and combination immunotherapy — Europe PMC PMID:41798957},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41798957},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e8d322d8d8e; sha256 654be182cf8f80e8c8bb8a0905dd271241e56550efdc24f2d106da02b4fdb27a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41798957. Agents can read the archived copy with the MCP tool read_document.